X0306 4 2021-08-04 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001214133 SCHELLER RICHARD H C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 1 0 0 See Remarks Common Stock 2021-08-04 4 M 0 13777 17.00 A 59637 D Common Stock 2021-08-04 4 S 0 13777 53.2276 D 45860 D Stock Option (Right to Buy) 17.00 2021-08-04 4 M 0 13777 0.00 D 2029-06-26 Common Stock 13777 39611 D Represents the weighted average sale price of the shares sold from $52.839 to $53.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote. The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date. Title: Chairman of Research and Development /s/ Yi Ching Yau, Attorney-in-Fact 2021-08-06